Drug Target Review2024-07-15T12:00:44
Researchers have developed a prediction model to ascertain breast cancer survivors’ risk of persistent taxane-induced peripheral neuropathy.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2024-01-26T13:22:42
Sponsored by bit.bio
2023-12-11T10:49:07
Sponsored by Leica Microsystems
2025-11-13T14:00:00
Sponsored by Cell Signaling Technology
2024-05-10T11:23:31
Sponsored by BellBrook Labs
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2024-02-01T12:06:43
Sponsored by Leica Microsystems
Site powered by Webvision Cloud